TABLE 2.

Group I vs. Group II: Parenchymal MTT ± SD (min)

GroupCaptoprilΔMTT
Before*After
I2.79 ± 0.703.44 ± 0.68§0.65 ± 0.66
II3.25 ± 1.483.29 ± 1.33§0.04 ± 1.68
  • * Baseline.

  • Change in MTT (post-captopril − pre-captopril).

  • Not significant (P > 0.05) comparing group II with group I.

  • § Not significant (P > 0.05) comparing group II with group I.

  • Not significant (P > 0.05) comparing group II with group I.